Inventor
STEENECK CHRISTOPH
DE23 patents
⚠️ This page may combine multiple inventors who share the name “STEENECK CHRISTOPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
5 patentsUS9850236B2Dec 26, 2017
Trifluoromethyl alcohols as modulators of RORγt
JANSSEN PHARMACEUTICA NV2 citations71
US10150762B2Dec 11, 2018
Trifluoromethyl alcohols as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations52
US9861618B2Jan 9, 2018
Thiazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations52
US10080744B2Sep 25, 2018
Thiazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations51
US9845319B2Dec 19, 2017
Amide substituted thiazoles as modulators of RORyt
JANSSEN PHARMACEUTICA NV0 citations40
PHENEX PHARMACEUTICALS AG
5 patentsUS10981908B2Apr 20, 2021
Aryl hydrocarbon receptor (AHR) modulator compounds
PHENEX PHARMACEUTICALS AG1 citations60
US9815851B2Nov 14, 2017
Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
PHENEX PHARMACEUTICALS AG1 citations51
US9458104B2Oct 4, 2016
Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ
PHENEX PHARMACEUTICALS AG2 citations51
US11376241B2Jul 5, 2022
Aryl hydrocarbon receptor (AhR) modulator compounds
PHENEX PHARMACEUTICALS AG0 citations49
US10301272B2May 28, 2019
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]
PHENEX PHARMACEUTICALS AG0 citations41
GILEAD SCIENCES INC
4 patentsUS9539244B2Jan 10, 2017
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC28 citations94
US10220027B2Mar 5, 2019
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC10 citations92
US9820979B2Nov 21, 2017
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC16 citations92
US10485795B2Nov 26, 2019
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC10 citations84
KINZEL OLAF
2 patentsUS9139539B2Sep 22, 2015
FXR (NR1H4) binding and activity modulating compounds
KINZEL OLAF42 citations95
US8940722B2Jan 27, 2015
Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease
KINZEL OLAF0 citations36
STEENECK CHRISTOPH
2 patentsUS8835441B2Sep 16, 2014
Heterobicyclic metalloprotease inhibitors
STEENECK CHRISTOPH3 citations55
US8946446B2Feb 3, 2015
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
STEENECK CHRISTOPH0 citations37